FDA Inspection 828388 — ImpactLife
The FDA completed an inspection of ImpactLife on April 22, 2013 in Danville, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 22, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Danville, IL (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 35 | 21 CFR 606.40 | Clean & orderly |